News

This article briefly summarizes novel aspects of selected United States (U.S.) patents involving controlled release or delivery that were issued from July 1 to December 31, 2015. Greater detail on each can be found on the U.S. patent website at…
  March Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease Business Wire: March 23, 2016 – CAMBRIDGE, MA, U.S.A. –…
The One Health concept is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, animals, and the environment. The goal of this initiative is to improve the lives of all species through knowledge…
Drugs and medical devices represent two modalities in treating disease, which display some fundamental differences. Drug molecules, when administered by conventional means, rarely remain in the body at therapeutic levels for extended time periods. Implantable devices such as…
IntroductionNowadays, most of the currently available ocular drugs are administered topically through eye drops,1 but their residence time in the eye is short, about 2 min…